Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2010
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
04/22/2010WO2010045580A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010WO2010045276A2 Azabenzimidazolones
04/22/2010WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010WO2010044885A2 Soluble mtor complexes and modulators thereof
04/22/2010WO2010044585A2 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/22/2010WO2010044543A2 Heterocyclic compound as protein kinase inhibitor
04/22/2010WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010WO2010043396A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
04/22/2010WO2010043315A1 Pesticidal (hetero) arylpyrrolidines
04/22/2010WO2010043052A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010WO2010012442A3 Insecticidal benzenedicarboxamide derivative
04/22/2010WO2010011864A3 Alpha-helix mimetic with functionalized pyridazine
04/22/2010WO2010011666A3 Indoline scaffold shp-2 inhibitors and cancer treatment method
04/22/2010WO2010011325A3 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling
04/22/2010WO2009095773A3 Novel heterocycles
04/22/2010US20100099915 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
04/22/2010US20100099681 Substituted 5-aminopyrazoles and use thereof
04/22/2010US20100099675 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
04/22/2010US20100099662 Hydrazone derivative
04/22/2010US20100099658 Di(arylamino)aryl compound
04/22/2010US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity
04/22/2010US20100099580 Photochemical methods and photoactive compounds for modifying surfaces
04/22/2010US20100098631 Novel-2-Heteroaryl Substituted Indoles 695
04/22/2010CA2740783A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010CA2740608A1 Pesticidal (hetero) arylpyrrolidines
04/22/2010CA2739884A1 Heterocyclic compounds as protein kinases inhibitors
04/22/2010CA2739466A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010CA2738849A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
04/22/2010CA2738609A1 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/21/2010EP2176249A2 New chemical compounds
04/21/2010EP2176237A1 Phthalazinone derivatives as inhibitors of parp-1
04/21/2010EP2176236A1 6-thioxo-pyridazine derivatives
04/21/2010EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
04/21/2010EP1258252B1 Integrin expression inhibitors
04/21/2010CN1923820B Novel carboxylic acid derivatives, their preparation and use
04/21/2010CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same
04/21/2010CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes
04/20/2010US7700771 antiinflammatory agents; antiarthritic agents
04/20/2010US7700765 DNA minor groove binding compounds
04/20/2010US7700638 Such as 7-(3-Chlorophenyl)-1-phenyl-5-trifluoromethylbenzimidazole; antianxiety agents; side effect reduction
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700624 To treat inflammatory diseases, immune diseases and cancer; 4-{[(1R3S)-3-isopropyl-3-({4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}carbonyl)cyclopentyl]amino}-1-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexanol; side effect reduction; improved long term safety profile; oral administration; half life
04/20/2010US7700620 C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
04/20/2010US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer
04/20/2010US7700602 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one
04/20/2010US7700594 mammalian Target Of Rapamycin (mTOR) kinase; for treatment of lymphoma or ovarian cancer
04/20/2010US7700589 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay
04/20/2010US7700552 Macrocyclic inhibitors of hepatitis C virus
04/20/2010CA2581865C Indazolone derivatives as 11b-hsd1 inhibitors
04/20/2010CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
04/20/2010CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/15/2010WO2010042887A2 Methods for preparing oxazolidinones and compositions containing them
04/15/2010WO2010042867A2 Activators of human pyruvate kinase
04/15/2010WO2010042758A2 Oxazole-pyridazine-oxazole alpha-helix mimetic
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2010041691A1 Optical recording medium containing metal complex of squarylium compound
04/15/2010WO2010041134A1 Process for preparing a 3-pyrrole subsituted 2-indolinone malate salt
04/15/2010WO2010040881A1 Aryl and heteroaryl derivatives of 2,2'-bipyrroles and preparation procedure
04/15/2010WO2010040826A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors
04/15/2010WO2010040663A1 Pyrrolidine n-benzyl derivatives
04/15/2010WO2010040661A1 Modulators for amyloid beta
04/15/2010WO2010017035A3 Inhibitors of iap
04/15/2010US20100094024 Active energy ray curable liquid composition and liquid cartridge
04/15/2010US20100094023 Benzoylpyrazoles and herbicide
04/15/2010US20100094006 Novel pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof
04/15/2010US20100093975 Used for peptide synthesis
04/15/2010US20100093945 Diffusion retardation in fluoroplastics
04/15/2010US20100093776 Organic Compounds and Their Uses
04/15/2010US20100093749 Compounds
04/15/2010US20100093746 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of cns diseases
04/15/2010US20100093735 Cytokine inhibitors
04/15/2010US20100093734 Cytokine inhibitors
04/15/2010US20100093731 Modulators for amyloid beta
04/15/2010US20100093730 Novel compounds as calcium channel blockers
04/15/2010US20100093727 Compounds and methods of use
04/15/2010US20100093711 Organic compounds
04/15/2010US20100093703 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
04/15/2010US20100093693 Modulators of cellular adhesion
04/15/2010US20100093668 N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
04/15/2010US20100092885 Image forming material
04/15/2010US20100092496 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors
04/15/2010DE102008050841A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/15/2010CA2738870A1 Pyrrolidine n-benzyl derivatives
04/15/2010CA2736924A1 Modulators for amyloid beta
04/14/2010EP2173739A1 Substituted cc-1065 analogs and their conjugates
04/14/2010EP2173736A2 Process for preparing voriconazole
04/14/2010EP2173734A2 Chemical compounds
04/14/2010EP2173728A2 Heterocyclic modulators of pkb
04/14/2010EP2173727A1 Novel herbicides
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 626